None
Quote | Vifor Pharma AG ADR (OTCMKTS:GNHAY)
Last: | $38.385 |
---|---|
Change Percent: | 0.0% |
Open: | $38.385 |
Close: | $38.385 |
High: | $38.385 |
Low: | $38.385 |
Volume: | 200 |
Last Trade Date Time: | 12/23/2022 09:40:50 am |
News | Vifor Pharma AG ADR (OTCMKTS:GNHAY)
UBS has upgraded DaVita ( NYSE: DVA ) to buy from neutral citing its ability to deliver EPS growth in the coming years. The firm upped its price target to $117 from $106 (~31% upside based on Thursday's close). Analyst Andrew Mok said he is confident the company can de...
The Swiss Agency for Therapeutic Products (Swissmedic) approved Cara Therapeutics ( NASDAQ: CARA ) and Vifor Fresenius Medical Care Renal Pharma's Kapruvia (difelikefalin) to treat moderate-to-severe pruritus (itching) associated with chronic kidney disease ...
Message Board Posts | Vifor Pharma AG ADR (OTCMKTS:GNHAY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Vifor Pharma AG ADR Company Name:
GNHAY Stock Symbol:
OTCMKTS Market:
CSL BEHRING AG PUBLISHES OFFER PROSPECTUS ON PUBLIC TENDER OFFER FOR ALL PUBLICLY HELD SHARES OF VIFOR PHARMA LTD. Ad hoc release pursuant to Art. 53 LR, Switzerland PR Newswire MELBOURNE, Australia and ST. GALLEN, Switzerland , Jan. 18, 2022 /PRNewswire/...